Cart
sales@molnova.com
D4R agonist-1
CAS No. 2826198-44-9
D4R agonist-1( —— )
Catalog No. M37215 CAS No. 2826198-44-9
D4R agonist-1 is a selective and potent D4R partial agonist (Ki:2.2 nM).D4R agonist-1 can be used to study neurological diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 645 | In Stock |
|
| 10MG | 798 | In Stock |
|
| 25MG | 1055 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameD4R agonist-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionD4R agonist-1 is a selective and potent D4R partial agonist (Ki:2.2 nM).D4R agonist-1 can be used to study neurological diseases.
-
DescriptionD4R agonist-1 (Compound 16f) is a D4R partial agonist (Ki: 2.2 nM). D4R agonist-1 is metabolically stable in rat and human liver microsomes. D4R agonist-1 can be used for research of neuropsychiatric disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2826198-44-9
-
Formula Weight338.47
-
Molecular FormulaC19H22N4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=1C=CC=CC1N2CCN(CC2)CCCC3=NC=4C=CC=CC4S3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Boateng CA, et al. Pharmacology and Therapeutic Potential ofBenzothiazole Analogues for Cocaine Use Disorder. J Med Chem. 2023 Aug 30.?
molnova catalog
related products
-
RP-5063
RP-5063 (Brilaroxazine) is a multimodal dopamine and serotonin modulator with partial agonist activity at DA D2, D3, D4, 5-HT1A, and 5-HT2ARs, and antagonist activity at 5-HT2B, 5-HT6 and 5-HT7Rs.
-
Pramipexole
A partial/full agonist of dopamine receptor with Ki of 3.9/2.2/0.5/5.1 nM for D2S/D2L/D3/D4, respeectively.
-
WAY-260022
WAY-260022 is an orally available and selective norepinephrine transporter protein inhibitor that displays inhibitory effects on serotonin and dopamine transporter proteins.
